Next Article in Journal
Isorhynchophylline, a Potent Plant Alkaloid, Induces Apoptotic and Anti-Metastatic Effects in Human Hepatocellular Carcinoma Cells through the Modulation of Diverse Cell Signaling Cascades
Previous Article in Journal
A Review of the Impact of Maternal Obesity on the Cognitive Function and Mental Health of the Offspring
Article

Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK

by 1,2,†, 1,†, 1,2 and 1,*
1
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2
University of Chinese Academy of Sciences, Beijing 100049, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Chang Won Choi
Int. J. Mol. Sci. 2017, 18(5), 1063; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051063
Received: 15 February 2017 / Revised: 26 April 2017 / Accepted: 9 May 2017 / Published: 19 May 2017
(This article belongs to the Section Bioactives and Nutraceuticals)
Although Panax ginseng is a famous traditional Chinese medicine and has been widely used to treat a variety of metabolic diseases including hyperglycemia, hyperlipidemia, and hepatosteatosis, the effective mediators and molecular mechanisms remain largely unknown. In this study we found that ginsenoside Rb2, one of the major ginsenosides in Panax ginseng, was able to prevent hepatic lipid accumulation through autophagy induction both in vivo and in vitro. Treatment of male db/db mice with Rb2 significantly improved glucose tolerance, decreased hepatic lipid accumulation, and restored hepatic autophagy. In vitro, Rb2 (50 µmol/L) obviously increased autophagic flux in HepG2 cells and primary mouse hepatocytes, and consequently reduced the lipid accumulation induced by oleic acid in combination with high glucose. Western blotting analysis showed that Rb2 partly reversed the high fatty acid in combination with high glucose (OA)-induced repression of autophagic pathways including AMP-activated protein kinase (AMPK) and silent information regulator 1 (sirt1). Furthermore, pharmacological inhibition of the sirt1 or AMPK pathways attenuated these beneficial effects of Rb2 on hepatic autophagy and lipid accumulation. Taken together, these results suggested that Rb2 alleviated hepatic lipid accumulation by restoring autophagy via the induction of sirt1 and activation of AMPK, and resulted in improved nonalcoholic fatty liver disease (NAFLD) and glucose tolerance. View Full-Text
Keywords: ginsenoside Rb2; NAFLD; type 2 diabetes; hepatosteatosis; autophagy; AMPK; sirt1 ginsenoside Rb2; NAFLD; type 2 diabetes; hepatosteatosis; autophagy; AMPK; sirt1
Show Figures

Figure 1

MDPI and ACS Style

Huang, Q.; Wang, T.; Yang, L.; Wang, H.-Y. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK. Int. J. Mol. Sci. 2017, 18, 1063. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051063

AMA Style

Huang Q, Wang T, Yang L, Wang H-Y. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK. International Journal of Molecular Sciences. 2017; 18(5):1063. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051063

Chicago/Turabian Style

Huang, Qi, Ting Wang, Liu Yang, and He-Yao Wang. 2017. "Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK" International Journal of Molecular Sciences 18, no. 5: 1063. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051063

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop